IMARK is a consortium created to combine the different modalities of biomarker discovery, tracing and detection in a single hub: from fluorescence microscopy to MRI to proteomics and more. As a consortium we are interested to pursue industrial collaborations, thereby broadening our portfolio and in turn offering our combined expertise and access to our state of the art facilities.

Examples from our combined portfolio of research include peripheral neuropathies, aging, regeneration, neurodegenerative diseases, radiopharmaceuticals for theranostics in the context of cancer treatment, human papilloma virus, glioblastoma organoids, and, SARS-CoV-2. We are experienced with 2D and 3D cell screening as well as work with laboratory animals.

Thanks to our expertise, cultivated over decades of research, assembly of analysis and experimental pipelines is streamlined. If you have a biomarker related question, we are here to tailor the methodology and find the answer!